Healthy Skepticism Library
Items published during the years 2000 to 2009
There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.
Page 120 of 144 pages ‹ First < 118 119 120 121 122 > Last ›
HSL18051
Thomas CP.
Incentive-based formularies.
N Engl J Med 2003 Dec 4; 349:(23):2186-8
http://content.nejm.org/cgi/content/extract/349/23/2186
HSL1521
Mathews A.
Federal Agencies Seek to Curb Abuse of Potent Painkillers
The Wall Street Journal 2003 Dec 3
HSL9
Promotion disguised as research
The Gazette 2003 Dec 2
HSL1519
Callahan P.
Lilly's Zyprexa Acted Similarly To Cheaper Drug
The Wall Street Journal 2003 Dec 2
HSL1520
Lerner S.
Medical Students Go Beyond Books to Learn About Activism
New York Times 2003 Dec 2
http://www.nytimes.com/2003/12/02/health/02EDUC.html
HSL1189
Mansfield PR.
Healthy Skepticism's new AdWatch: understanding drug promotion.
Med J Aust 2003 Dec 1-15; 179:(11-12):644-5
http://www.mja.com.au/public/issues/179_11_011203/man10667_fm.html
HSL1248
Baena Diez JM, Lopez Mompo C, Lopez Gosp D, Martinez Martinez JL, Ellacuria Torres A, Fuentes Rodriguez S.
[Good morning, Mr. Representative. Anything new to tell us about? Analysis of the pharmacological products introduced by the drugs industry into a health district]
Aten Primaria 2003 Dec 01; 32:(10):557-61
http://www.ncbi.nlm.nih.gov/pubmed/14697177
HSL1250
Antonuccio DO, Danton WG, McClanahan TM.
Psychology in the prescription era: building a firewall between marketing and science.
Am Psychol 2003 Dec 01; 58:(12):1028-43
http://content.apa.org/journals/amp/58/12/1028
HSL1516
Spears T.
Drug companies get doctors to endorse tainted medical research
Victoria Times 2003 Dec 1
HSL1517
Court Declines Patent Case Over 'Off-Label' Drug Uses
Wall Street Journal 2003 Dec 1
HSL1518
Guyatt G.
Beware of phony citizens' groups sponsored by drug companies: Patient advocacy groups are often not what they seem
2003 Dec 1
HSL1837
Mur E, Hartig F, Blumenthal-Hausmann E, Falkenbach A.
[Quality assurance in the teaching of medical students illustrated by the example of spa therapy for rheumatic diseases]
.
Forsch Komplementarmed Klass Naturheilkd 2003 Dec 01; 10:(6):298-302
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=FKM2003010006298
HSL1902
Rutledge P, Crookes D, McKinstry B, Maxwell SR.
Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? Results from a questionnaire survey.
Pharmacoepidemiol Drug Saf. 2003 Dec 01; 12:(8):663-7.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=14762982&query_hl=3
HSL5754
Warner TD, Gluck JP.
What do we really know about conflicts of interest in biomedical research?
Psychopharmacology (Berl) 2003 Dec 01; 171:(1):36-46
http://www.springerlink.com/(13h2cx45krkzla45np3myu45)/app/home/contribution.asp?referrer=parent&backto=issue,6,17;journal,62,719;linkingpublicationresults,1:100390,1
HSL7563
Young D.
FDA examines direct-to-consumer advertising data.
Am J Health Syst Pharm 2003 Dec 1; 60:(23):2420,
http://www.ajhp.org/cgi/reprint/60/23/2420
HSL11443
Coote W.
There is such a thing as a free lunch?
Med J Aust 2003 Dec 1-15; 179:(11-12):672
http://www.mja.com.au/public/issues/179_11_011203/coote_letter_011203.html
HSL18047
Ooi ES, Chapman S.
An analysis of newspaper reports of cancer breakthroughs: hope or hype?
Med J Aust 2003 Dec 1-15; 179:(11-12):639-43
http://www.ncbi.nlm.nih.gov/pubmed/14636141
HSL1202
Katz A.
Observations and advertising: controversies in the prescribing of hormone replacement therapy
Health Care Women Int 2003 Dec; 24:(10):927-39
HSL1206
Hildebrandt M, Ludwig WD.
Clinical research and industrial sponsoring: avenues towards transparency and credibility.
Onkologie 2003 Dec; 26:(6):529-34
http://content.karger.com/produktedb/produkte.asp?typ=fulltext&file=ONK2003026006529
HSL1247
Baker CB, Johnsrud MT, Crismon ML, Rosenheck RA, Woods SW.
Quantitative analysis of sponsorship bias in economic studies of antidepressants.
Br J Psychiatry 2003 Dec; 183:498-506:
http://bjp.rcpsych.org/cgi/content/full/183/6/498
HSL9883
Votano J.
The high cost of adverse drug reactions
Current Drug Discovery 2003 Dec; 9-10
HSL10286
Horikoshi A, Takei K, Sawada S.
Effects of lower dose of imatinib to CML patients.
Leuk Res 2003 Dec; 27:(12):1167
http://linkinghub.elsevier.com/retrieve/pii/S0145212603001012
HSL858
Jureidini J, Mansfield P, Menkes D.
The statin wars.
Lancet 2003 Nov 29; 362:(9398):1855
HSL18054
Burton B
Drug companies succeed in keeping payments to doctors secret
BMJ 2003 Nov 29; 327:(7426):1248
http://www.bmj.com/cgi/content/extract/327/7426/1248-a
HSL18055
Webster P
FDA chief attacks Canada's drug price controls.
Lancet 2003 Nov 29; 362:(9398):1816
http://linkinghub.elsevier.com/retrieve/pii/S0140-6736(03)14949-5
HSL18056
Tite L
Drug company pushes for all children under 2 to be vaccinated against pneumonia
BMJ 2003 Nov 29; 327:(7426):1249
http://www.bmj.com/cgi/content/extract/327/7426/1249-a
HSL1495
Marcus A.
Superiority of New Schizophrenia Drug Challenged
HealthDayNews 2003 Nov 25
HSL18053
Gandey A
Bupropion: 1 drug, 4 different brand names
CMAJ 2003 Nov 25; 169:(11):1202
http://www.cmaj.ca/cgi/content/full/169/11/1202
HSL18057
Moynihan R.
Should drug companies be allowed to sponsor Cochrane reviews?
CMAJ 2003 Nov 25; 169:(11):1201
http://www.cmaj.ca/cgi/content/full/169/11/1201
HSL1492
Branswell H.
Group that advises doctors on preventive health care loses funding, must fold
Canadian Press 2003 Nov 24
HSL1493
Goldstein A.
Medicare Bill Would Enrich Companies: Hundreds of Billions for Employers, Health Firms
Washington Post Staff 2003 Nov 24
HSL1494
Landers P.
With Dry Pipelines, Big Drug Makers Stock Up in Japan: Shunning High-Tech Gizmos, The Asian Scientists Score With Traditional Lab Work
Wall Street Journal 2003 Nov 24
HSL1490
Mercola J.
World's Largest Media Source Controlled by World's Largest Drug Company
Mercola.com 2003 Nov 23
HSL1491
Hall S.
Quest for hot new drugs spikes costs: High failure rate, time they take to develop hurt companies
The Detroit News 2003 Nov 23
HSL9927
de Haan GJ, Carpay JA, van Donselaar CA.
Antiepileptic primidone shortly to be withdrawn from sale: change medication now.
Ned Tijdschr Geneeskd 2003 Nov 22; 147:(47):2325-6
HSL18058
Garattini S, Bertele' V, Li Bassi L.
European Council waters down European Parliament's drug-regulatory legislation.
Lancet 2003 Nov 22; 362:(9397):1688-9
http://linkinghub.elsevier.com/retrieve/pii/S0140673603148829
HSL18059
Aronson JK, Ferner RE.
Joining the DoTS: new approach to classifying adverse drug reactions.
BMJ 2003 Nov 22; 327:(7425):1222-5
http://www.bmj.com/cgi/content/full/327/7425/1222?view=long&pmid=14630763
HSL5850
Toop L.
Last time around for DTCA
N Z Med J. 2003 Nov 21; 116:(1186):U693
HSL1488
Hallam K.
Merck Leads Industry in Spending to Lobby on Medicare
Bloomberg News 2003 Nov 20
HSL1489
Walker B, Sucher L.
Chemical Industry's Secret Plan to Attack California's Anti-toxics trend: Memo Calls for Phony Front Groups, Spying on Activists
Environmental Working Group 2003 Nov 20
HSL10
Wilde Mathews A, Steinberg B
FTC Examines Health Claims In KFC's Ads
The Wall Street Journal 2003 Nov 19
http://traynota.blogspot.com/
HSL11
Greenhouse S.
Capping the Cost of Atrocity: Survivor of Nazi Experiments Says $8,000 Isn't Enough
The New York Times 2003 Nov 19
http://www.nytimes.com/2003/11/19/nyregion/capping-the-cost-of-atrocity-survivor-of-nazi-experiments-says-8000-isn-t-enough.html?pagewanted=1?pagewanted=1
HSL1486
Simon B.
Canada Rebuffs U.S. on Prescription Drugs
The New York Times 2003 Nov 19
http://www.nytimes.com/2003/11/19/business/canada-rebuffs-us-on-prescription-drugs.html
HSL1487
Hallam K.
Calpers Opposes Medicare Compromise, Asks for Subsidy
Bloomberg News 2003 Nov 19
HSL18075
Gottlieb S
A fifth of Americans contact their doctor as a result of drug advertising
BMJ 2003 Nov 19; 325:(7369):854
http://www.bmj.com/cgi/content/full/325/7369/854/b
HSL1484
Relman A.
Your Doctor's Drug Problem
The New York Times 2003 Nov 18
http://www.nytimes.com/2003/11/18/opinion/your-doctor-s-drug-problem.html
HSL1485
White E.
Group of House Rx Reimport Backers:Seek Stronger Provision in Medicare Bill
The Bureau of National Affairs, Inc 2003 Nov 18
HSL9928
Doran E, Henry DA.
The PBS community awareness campaign: how helpful is blaming patients?
Med J Aust 2003 Nov 17; 179:(10):544-5
http://www.mja.com.au/public/issues/179_10_171103/dor10622_fm.html
HSL1483
Burne J.
Just how effective are medical screening tests? More than you need to know?
The Guardian 2003 Nov 15
http://www.guardian.co.uk/society/2003/nov/15/medicineandhealth.publichealth
HSL1482
Dodge C.
FDA Won't Rule Out Action Against States Over Imports
Bloomberg 2003 Nov 14
HSL1481
Hallam K.
Bush, Retirees, Insurers Push for Medicare Measure
Bloomberg 2003 Nov 13
HSL18062
Rothman DJ
The Merck Druggernaut: The Inside Story of a Pharmaceutical Giant by Fran Hawthorne The Big Fix: How the Pharmaceutical Industry Rips Off American Consumers Katharine Greider
NEJM 2003 Nov 13; 349:(20):1980
http://intl-content.nejm.org/cgi/content/full/349/20/1980
HSL859
Katz D, Mansfield P, Goodman R, Tiefer L, Merz J.
Psychological aspects of gifts from drug companies.
JAMA 2003 Nov 12; 290:(18):2404-5
http://jama.ama-assn.org/cgi/content/full/290/18/2404-b
HSL1480
Wilde Mathews A, Landers P.
An FDA Shift Could Transform Market for Statins: Agency Will Consider Allowing Over-the-Counter Sales Of Cholesterol Medicine
The Wall Street Journal 2003 Nov 12
HSL12
Murray A.
Drug Makers' Paths Of Influence Need To Be Less Hidden
The Wall Street Journal 2003 Nov 11
HSL1478
Global rise in use of fake drugs
BBC News 2003 Nov 11
http://news.bbc.co.uk/2/hi/health/3261385.stm
HSL18061
Sibbald B
Alberta MDs irate over prescribing privacy issue
CMAJ 2003 Nov 11; 169:(10):1066
http://www.cmaj.ca/cgi/content/full/169/10/1066
HSL1476
Picard A.
Health law may protect Ottawa
The Globe and Mail 2003 Nov 10
http://www.freedomofchoiceinhealthcare.ca/Articles/HealthCanada/healthcanada7.html
HSL1477
Sex, Drugs And Middle Age
CBC-TV 2003 Nov 10
HSL13
Mokhiber R.
Say No to Silicone
The Corporate Crime Reporter 2003 Nov 8
http://www.commandtrust.org
HSL1475
Adams P.
A dose of healthy suspicion
The Australian 2003 Nov 8
HSL9937
Bounameaux H.
Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery.
Lancet 2003 Nov 8; 362:(9395):1581
http://linkinghub.elsevier.com/retrieve/pii/S0140673603147502
HSL1473
Rowland C.
FDA mulls drug-import action: Agency says it may charge states, cities
The Boston Globe 2003 Nov 7
HSL1474
Kurt K.
Judge OKs Shutdown of Canada Drugs Firm
Associated Press 2003 Nov 7
HSL20150
Saunders B
DTCA and the cost of asthma inhalers
New Zealand Medical Journal 2003 Nov 7; 116:(1185 ):
http://journal.nzma.org.nz/journal/116-1185/672/
HSL1472
Rutkowski C.
More Generic Drugs Could Cut Costs, Save Milions Each Year: Study finds that Manitoba could save significantly if generic drugs were used more often
Public Affairs Department 2003 Nov 6
HSL9943
Kloner RA, Brindis RG, Cheitlin MD, Kuritzky L, Miller TA, Padma-Nathan H, Rosen RC.
Roundtable discussion: tadalafil study group.
Am J Cardiol 2003 Nov 6; 92:(9A):58M-65M
http://linkinghub.elsevier.com/retrieve/pii/S0002914903008269
HSL4476
Carter H, Mansfield P.
Eye on ads.
Australian Doctor Weekly 2003 Nov 5
HSL1470
Teske S.
Potential House-Senate Compromise On Medicare Bill Outlined in Document
The Bureau of National Affairs 2003 Nov 3
HSL1471
Mathews A.
FDA Issues Rules on New Era Of 'Personalized Medicine'
The Wall Street Journal 2003 Nov 3
HSL1469
Extensive records analyzed for series
The Miami Herald 2003 Nov 2
HSL5376
Salmon P, Hall GM.
Patient empowerment and control: a psychological discourse in the service of medicine.
Soc Sci Med 2003 Nov 01; 57:(10):1969-80
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6VBF-4899V1S-4&_coverDate=11%2F30%2F2003&_alid=421169285&_rdoc=1&_fmt=&_orig=search&_qd=1&_cdi=5925&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=0108299694b7ad851b9ec164f0cf893a
HSL9938
Scott PW.
Supply of veterinary medicines.
Vet Rec 2003 Nov 1; 153:(18):572
HSL18064
Chalmers I, Rounding C, Lock K.
Descriptive survey of non-commercial randomised controlled trials in the United Kingdom, 1980-2002.
BMJ 2003 Nov 1; 327:(7422):1017
http://www.bmj.com/cgi/content/full/327/7422/1017?view=long&pmid=14593034
HSL18066
Dobson R
Industry sponsored studies twice as likely to have positive conclusions about costs
BMJ 2003 Nov 1; 327:(7422):106
http://www.bmj.com/cgi/content/full/327/7422/1006-b
HSL1194
Krueger KP, Felkey BG, Berger BA.
Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative.
J Am Pharm Assoc (Wash DC) 2003 Nov-Dec; 43:(6):668-78
HSL1211
Gale EA.
Between two cultures: the expert clinician and the pharmaceutical industry.
Clin Med 2003 Nov-Dec; 3:(6):538-41
http://www.ingentaconnect.com/content/rcop/cm/2003/00000003/00000006/art00015?token=00681f293f7ee784b3143d54e6b63734f582a2f4876753375726f4f2858595c5f3b3b476752486b25707b514a2f425aca8359cca
HSL1802
Wager E.
Good practice in publication of clinical trial results.
Br J Psychiatry 2003 Nov; 183:464-5:
http://bjp.rcpsych.org/cgi/content/full/183/5/464-a
HSL1912
Monaghan MS, Galt KA, Turner PD, Houghton BL, Rich EC, Markert RJ, Bergman-Evans B.
Student understanding of the relationship between the health professions and the pharmaceutical industry.
Teach Learn Med 2003 Win; 15:(1):14-20
HSL1914
Millstein LG.
Prescription drug advertising: is it a driving force on drug pricing?
N C Med J 2003 Nov-Dec; 64:(6):289-91
HSL9794
Gonzalez Hernando S, Gonzalez Mieres C, Diaz Martin AM.
Intention of purchasing generic prescription drugs on the part of consumers in Asturias, Spain
Rev Esp Salud Publica. 2003 Nov; 77:(6):691-9
HSL9889
Tatara K.
Prescribing and dispensing in Japan: conflict of interest?
Clin Med 2003 Nov-Dec; 3:(6):555
http://www.ingentaconnect.com/content/rcop/cm/2003/00000003/00000006/art00019?token=00561dd74219e401fad63726e2d2954496f642f466f256720297d7625627b2e7b4624246a6f7c49ac6bc4a
HSL9891
Levy C, Bonastre J.
[The cost of chemotherapy].
Bull Cancer. 2003 Nov; 90:(11):976-82
http://www.john-libbey-eurotext.fr/fr/revues/medecine/bdc/e-docs/00/03/FC/CE/resume.md
HSL9895
Kardos P.
Fixed combinations as a first line treatment for all degrees of severity in asthma?
Pneumologie 2003 Nov; 57:(11):671-3
http://www.thieme-connect.com/DOI/DOI?10.1055/s-2003-44267
HSL9901
Pearson SA, Ross-Degnan D, Payson A, Soumerai SB.
Changing medication use in managed care: a critical review of the available evidence.
Am J Manag Care 2003 Nov; 9:(11):715-31
http://web.archive.org/web/20041206205928/http://www.ajmc.com/article.cfm?ID=2486
HSL9902
Minhas R.
Statins: is OTC actually OTT?
Int J Clin Pract 2003 Nov; 57:(9):750-1
HSL9912
Jackevicius CA, Tu K, Filate WA, Brien SE, Tu JV; Canadian Cardiovascular Outcomes Research Team.
Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001.
Can J Cardiol 2003 Nov; 19:(12):1359-66
HSL9913
Little S.
The future is personal
Current Drug Discovery 2003 Nov; 9-10
HSL9930
Erasmus J.
Ritalin--on the bandwagon?
S Afr Med J 2003 Nov; 93:(11):805
HSL9932
Camp SL, Wilkerson DS, Raine TR.
The benefits and risks of over-the-counter availability of levonorgestrel emergency contraception.
Contraception 2003 Nov; 68:(5):309-17
http://linkinghub.elsevier.com/retrieve/pii/S0010782403002269
HSL9944
Hogan WR, Tsui FC, Ivanov O, Gesteland PH, Grannis S, Overhage JM, Robinson JM, Wagner MM; Indiana-Pennsylvania-Utah Collaboration.
Detection of pediatric respiratory and diarrheal outbreaks from sales of over-the-counter electrolyte products.
J Am Med Inform Assoc 2003 Nov-Dec; 10:(6):555-62
http://www.jamia.org/cgi/content/full/10/6/555
HSL9945
Hoch I, Heymann AD, Kurman I, Valinsky LJ, Chodick G, Shalev V.
Countrywide computer alerts to community physicians improve potassium testing in patients receiving diuretics.
J Am Med Inform Assoc 2003 Nov-Dec; 10:(6):541-6
http://www.jamia.org/cgi/content/full/10/6/541
HSL9950
Brass EP, Weintraub M.
Label development and the label comprehension study for over-the-counter drugs.
Clin Pharmacol Ther 2003 Nov; 74:(5):406-12
http://www.nature.com/clpt/journal/v74/n5/abs/clpt2003500a.html;jsessionid=69F78644AC0571CEFD32EA375F17CA21
HSL13369
Moncrieff J, Double D.
Double blind random bluff.
Ment Health Today 2003 Nov; :24-6:
http://www.ncbi.nlm.nih.gov/pubmed/14689600
HSL16133
Murray E, Lo B, Pollack L, Donelan K, Lee K.
Direct-to-consumer advertising: physicians' views of its effects on quality of care and the doctor-patient relationship.
J Am Board Fam Pract. 2003 Nov-Dec; 16:(6):513-24
http://www.jabfm.org/cgi/content/full/16/6/513
HSL1465
Evenson B.
Heart doctors redefine 'normal': Lower cholesterol, lower blood pressure now expected
National Post 2003 Oct 30
HSL1466
Petersen M.
Campaign for Medical Device Bypasses Doctors
New York Times 2003 Oct 30
http://www.nytimes.com/2003/10/30/business/the-media-business-advertising-campaign-for-medical-device-bypasses-doctors.html
HSL1467
Harris G.
Drug Makers’ New Intensity in Defense of U.S. Borders
The New York Times 2003 Oct 30
http://www.nytimes.com/2003/10/30/business/drug-makers-new-intensity-in-defense-of-us-borders.html?fta=y&archive:article_related
HSL1468
Cassels A.
Is Big Pharma pulling Canada's chain?
The Globe and Mail 2003 Oct 30
HSL14
Drug firm hit with $200-million class action: Quebecer says he was diagnosed with liver damage while on antidepressant
Montreal Gazette 2003 Oct 29
Page 120 of 144 pages ‹ First < 118 119 120 121 122 > Last ›
